- Home
- DSGN vs CGC Comparison
DSGN vs CGC Comparison
Compare DSGN & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- CGC
- Stock Information
- Founded
- DSGN 2017
- CGC 2009
- Country
- DSGN United States
- CGC Canada
- Employees
- DSGN N/A
- CGC N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- CGC Pharmaceuticals and Biotechnology
- Sector
- DSGN Health Care
- CGC Health Care
- Exchange
- DSGN Nasdaq
- CGC Nasdaq
- Market Cap
- DSGN 348.2M
- CGC 379.3M
- IPO Year
- DSGN 2021
- CGC N/A
- Fundamental
- Price
- DSGN $4.87
- CGC $2.23
- Analyst Decision
- DSGN Hold
- CGC Sell
- Analyst Count
- DSGN 3
- CGC 1
- Target Price
- DSGN $7.00
- CGC $2.00
- AVG Volume (30 Days)
- DSGN 220.6K
- CGC 5.9M
- Earning Date
- DSGN 03-18-2025
- CGC 02-07-2025
- Dividend Yield
- DSGN N/A
- CGC N/A
- EPS Growth
- DSGN N/A
- CGC N/A
- EPS
- DSGN N/A
- CGC N/A
- Revenue
- DSGN N/A
- CGC $207,628,706.00
- Revenue This Year
- DSGN N/A
- CGC N/A
- Revenue Next Year
- DSGN N/A
- CGC $2.35
- P/E Ratio
- DSGN N/A
- CGC N/A
- Revenue Growth
- DSGN N/A
- CGC N/A
- 52 Week Low
- DSGN $2.25
- CGC $2.15
- 52 Week High
- DSGN $7.77
- CGC $14.92
- Technical
- Relative Strength Index (RSI)
- DSGN 42.19
- CGC 26.31
- Support Level
- DSGN $3.71
- CGC $2.15
- Resistance Level
- DSGN $6.81
- CGC $2.29
- Average True Range (ATR)
- DSGN 0.50
- CGC 0.15
- MACD
- DSGN -0.10
- CGC -0.02
- Stochastic Oscillator
- DSGN 37.42
- CGC 8.70
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.